Type Size
Intended for US health care professionals only

Symptomatic Vitreomacular Adhesion (VMA)

Symptomatic VMA is an increasingly recognized sight-threatening disease of the vitreoretinal interface.1 VMA may lead to symptoms such as metamorphopsia, decreased visual acuity, and central visual field defect.2-4 VMA can cause traction resulting in anatomical damage, which may lead to severe visual consequences, including macular hole (Figure 1).

Figure 1. VMA can cause traction resulting in anatomical damage, which may lead to severe visual consequences.

The vitreous cavity is filled with a gel-type substance consisting mostly of water, with macromolecules such as hyaluronic acid, proteins, and collagens comprising the remainder.7 The posterior vitreous cortex attaches to the internal limiting membrane (ILM) via a matrix that includes collagen fibrils, fibronectin, and laminin.7,8 The anatomic junction of the vitreous and retina is referred to as the vitreoretinal interface (VRI; Figure 2).

Figure 2. Components of the VRI include the vitreous cortex and the internal limiting membrane (ILM), which separates the retina from the vitreous, and is composed of a matrix that includes collagen fibrils, laminin, and fibronectin.

The natural aging process of the vitreous results in its liquefaction and separation from the retina in many eyes.9-11 In some eyes, the adhesion between the vitreous and the macula does not weaken sufficiently to allow for separation of vitreous, resulting in a condition known as VMA (Figure 3). This persistent adhesion can lead to symptoms (ie, symptomatic VMA), including metamorphopsia (distorted vision), decreased visual acuity and central visual field defect.2-4 These symptoms are due to the traction caused by the persistent VMA at the vitreoretinal interface, often referred to as vitreomacular traction (VMT). VMT can lead to the formation of a macular hole (Figure 3).5,12

Figure 3. VMA occurs when the vitreous fails to completely separate from the retina during normal liquefaction and weakening of the normal adhesions between the posterior vitreous cortex and the ILM.

For more on diagnosis and management, click here.

* Eye Clinic, Department of Clinical Science “Luigi Sacco”, Sacco Hospital, University of Milan, Milan, Italy.

Symptomatic VMA Vireomacular Traction Macular Hole

You are now leaving www.sVMAinfo.com, a ThromboGenics, Inc. website. Links to external websites are provided solely as a resource and convenience to our visitors, and the inclusion of such links does not imply any endorsement or approval of any content or information contained within or accessible from the linked website.  ThromboGenics, Inc. accepts no responsibility for the content of these websites and has no control over the opinions, claims, or comments expressed therein. By continuing to the linked site you agree to the foregoing and understand that you will be subject to the external site's terms of use and privacy policies.

Do you wish to leave this site?

Yes No